Citigroup Maintains Buy on Tenet Healthcare, Raises Price Target to $90
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Jason Cassorla maintains a 'Buy' rating on Tenet Healthcare (NYSE:THC) and raises the price target from $83 to $90.
August 01, 2023 | 10:44 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup maintains a 'Buy' rating on Tenet Healthcare and raises the price target from $83 to $90, which could lead to a positive market reaction.
The raised price target by Citigroup indicates a positive outlook for Tenet Healthcare. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100